The Last 25 Years of PSA
Dr. Michael K. Brawer spoke at the 25th International Prostate Cancer Update on Thursday, January...
Read More
Michael Brawer, MD
Dr. Brawer, MD, is Vice President of Medical Affairs for Urology at Myriad Genetics Laboratories in Salt Lake City, Utah. Dr. Brawer joined Myriad from GTx, Inc., where he served as Executive Director of Medical Affairs and Clinical Development from 2009 until 2012. Prior to this, he was Chief Medical Officer at Tokai Pharmaceuticals from 2007 until 2009, and from 2006 to 2007, Dr. Brawer was Interim Chief Medical Officer at Threshold Pharmaceuticals. In 1998, he helped found the Northwest Prostate Institute, a community hospital focused on clinical practice, community outreach, basic and clinical research, and medical education, and served as Director until 2007. From 1986 to 1998, he held various academic appointments, first at the University of Arizona and then at the University of Washington where he was Professor of Urology and Adjunct Professor of Pathology. Dr. Brawer has published more than 200 scientific papers, 10 books, and 74 book chapters and is the recipient of 28 peer-reviewed competitive grants. In 1998, the American Urological Association bestowed upon him the Gold Cystoscope, given annually to a urologist distinguished by outstanding contributions to the profession within 10 years of completion of residency training. Dr. Brawer received his bachelor and medical degrees from the University of California, Los Angeles, where he also completed a fellowship in pathology. He completed his residency in urology at Stanford University Medical Center, where from 1985 to 1986 he was Chief Resident in Urology.
Disclosures:Talks by Michael Brawer, MD